Ani Deshpande, Ph.D.

Press Release

Scientists identify potential drug candidates for deadly pediatric leukemia

Scientists at Sanford Burnham Prebys have shown that two existing drug candidates—JAK inhibitors and Mepron—hold potential as treatments for a deadly acute myeloid leukemia (AML) subtype that is more common in children.
Conrad Prebys Foundation Award

Blog

Conrad Prebys Foundation provides $3 million for pediatric brain cancer research

The Conrad Prebys Foundation provides $3 million to Robert Wechsler-Reya, Ph.D., and his team of researchers to advance a potential drug to treat medulloblastoma—the most common malignant brain tumor in children.
JEM logo

Paper of the Week

Regnase-1 is essential for B cell homeostasis to prevent immunopathology

blood logo

Paper of the Week

A JAK/STAT-Mediated Inflammatory Signaling Cascade Drives Oncogenesis in AF10-Rearranged AML

Daniel Million in lab wearing lab coat and smiling

Blog

Alumni adventures: Catching up with student intern Daniel Million

Million reflects on how a summer internship at Sanford Burnham Prebys accelerated his scientific career.

Sanford Burnham Prebys Newsletter

Subscribe to our monthly email newsletter Discoveries.

 

Connect with us

Follow us on social media for the latest from Sanford Burnham Prebys.